Here’s What Hedge Funds Think About Novartis AG (NVS)
Before we spend countless hours researching a company, we’d like to analyze what insiders, hedge funds and billionaire investors think of the stock......(read more)
Posts Tagged ‘NYSE:NVS’
Were Hedge Funds Right About Novartis AG (NVS)?
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions......(read more)
Here is What Hedge Funds Think About Novartis AG (NVS)
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by......(read more)
Billionaire Ken Fisher is Bullish About These Dividend Stocks
Fisher Investments was founded in 1979 by billionaire Ken Fisher. The fee-only investment adviser managed more than $100 billion in assets as of July......(read more)
Hedge Fund and Insider Trading News: Third Point, Mike Novogratz, Know Labs Inc (KNWN), Novartis AG (NVS), and More
Nestle Counts on Better Second Half to Keep Third Point at Bay (Reuters) ZURICH (Reuters) – Nestle (NESN.S) Chief Executive Mark Schneider said......(read more)
30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets
The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers. Increasingly sedentary......(read more)
15 Best Selling Most Profitable Drugs of All Time
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest......(read more)
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and......(read more)
10 Most Profitable Companies In Europe
The 10 most profitable companies in Europe are responsible for some of the top-class products and services that are being provided on just about every......(read more)
10 Most Advanced Technologies In The World Today
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators. Technology paints......(read more)
Flexi-Pricing Scheme Unveiled For Novartis AG (ADR) (NVS) Kisqali In The Face Of Stiff Competition
After recently getting the approval of the U.S. Food and Drug Administration, Novartis AG (ADR) (NYSE:NVS) has announced that a flexible pricing system......(read more)
Positive Results For AbbVie Inc (ABBV) Humira Biosimilar Reported By Novartis AG (ADR) (NVS)
A Phase III study has shown that GP2017, which is manufactured by Sandoz, a unit of Novartis AG (ADR) (NYSE:NVS), has shown positive results as a Humira......(read more)
Novartis AG (ADR) (NVS) Fined And Some Products To Be Temporarily Suspended In South Korea
Novartis AG (ADR) (NYSE:NVS) has been fined approximately $174,000 in South Korea after the company was found guilty of bribing physicians in order to......(read more)
Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks
By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system.......(read more)
Novartis AG (ADR) (NVS) Greater Use Of Technology In Transforming Medical Education
Novartis AG (ADR) (NYSE:NVS) is quickly entering into an engagement with the use of digital technology. The idea is to enhance and increase interaction......(read more)
10 Most Diverse Companies In The US
Diversity is a hot topic in the US corporate world, and the 10 most diverse companies in the US are showing the way in terms of how a workplace and its......(read more)
11 Largest Pharmaceutical Companies In The World
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest......(read more)
Novartis AG (ADR) (NVS) Agrees To $50 Million Deal With Conatus Pharmaceuticals Inc (CNAT)
Novartis AG (ADR) (NYSE:NVS) and Conatus Pharmaceuticals Inc (NASDAQ:CNAT) will jointly develop Conatus drug emricasan. This has resulted from the duo......(read more)
What Smart Money Has To Say About Novartis AG (ADR) (NVS)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research......(read more)
Novartis AG (ADR) (NVS) Acquires Selexys Pharmaceuticals Corp.
Novartis AG (ADR) (NYSE:NVS) has recently acquired Selexys Pharmaceuticals Corp. after receiving results from the SUSTAIN clinical trial, a Phase II clinical......(read more)
5 Healthcare Stocks Kahn Brothers Is Bullish On
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109......(read more)
Novartis AG (ADR) (NVS) And Pfizer Inc. (PFE) Are In A Race To Gain Favor In Breast Cancer
Novartis AG (ADR) (NYSE:NVS) CDK4/6 breast cancer drug remains on track with Pfizer Inc. (NYSE:PFE)‘s Ibrance. The pharma giant has already obtained......(read more)
Novartis AG (NVS) Relocates NITD To California
James Bradner, Novartis AG (NYSE:NVS) Novartis Institutes for BioMedical Research President, has recently confirmed that the company will move the Novartis......(read more)
Does Novartis AG (NVS) Have The Solution For Malaria?
Results for a potentially game-changing proof of concept study were just published concerning malaria by Novartis AG (NYSE:NVS) in the New England Journal......(read more)
Here’s What’s Important With The Novartis AG (ADR) (NVS) MS Data
Novartis AG (ADR) (NYSE:NVS) just put out data from its multiple sclerosis (MS) trial, and it looks as if the company is winning the race to bring a drug......(read more)
Novartis AG (NVS) Announces Positive Phase III Results For MS Drug
Novartis AG (NYSE:NVS) has announced that the Phase III EXPAND study, which is evaluating the efficacy and safety of oral, once daily, BAF312 in secondary......(read more)
Colombia Makes Good On Its Threat Against Novartis AG (NVS)
After negotiations with Novartis AG (NYSE:NVS) to lower the price of key leukemia drug Gleevec broke off, the Colombian government is set to take matters......(read more)
Hedge Funds Aren’t Crazy About Novartis AG (ADR) (NVS) Anymore
We can judge whether Novartis AG (ADR) (NYSE:NVS) is a good investment right now by following the lead of some of the best investors in the world and......(read more)
Billionaire Jim Simons’ Top High-Dividend Stock Picks
Most individual investors invest in dividend-paying stocks to benefit from the steady streams of dividend checks, but can also take advantage of stock......(read more)
Chiasma Inc (CHMA)’s Shares Jump 35% On First Day Of Trading
The shares of Chiasma Inc (NASDAQ:CHMA) are up by 25% on its first day of trading at $20.02 per share as of the time of writing. The biopharmaceutical......(read more)
11 Biggest Generic Drug Companies in the World
When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years. Names like Novartis......(read more)
Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday. After adding more than 1......(read more)
The 10 Largest Pharmaceutical Companies In the World
Wondering which are the largest pharmaceutical companies in the world? The collective biotech and pharmaceutical industry is known to be one of the most......(read more)
International Business Machines Corp. (IBM) and Google Inc (GOOGL): Hank Smith Love These Stocks
In a discussion with Fox Business News anchors David Asman and Liz Claman from the show ‘After the bell,’ Hank Smith, who is the CIO of Haverford,......(read more)
Novartis AG (ADR) (NVS) Beats Analyst Estimates; Is Expected To Perform Well Backed By Recent Deals
In an interview with Bloomberg, Odile Rundquist, who is an analyst at Helvea, discusses on the second Qtr. results of the world’s largest drug maker......(read more)
Foreign Companies News: Rio Tinto plc (ADR) (RIO), Novartis AG (ADR) (NVS), GlaxoSmithKline plc (ADR) (GSK)
Rio Tinto plc (ADR) (NYSE:RIO), the world’s second-biggest mining company, is now seeing iron ore trading close to $100 per metric ton. Chief Executive......(read more)
The Pharmaceutical Industry’s 10 Biggest R&D Budgets
Innovation is everything when it comes to the pharmaceutical sector. Behind those glorious 75%-plus gross margins associated with branded and patented......(read more)
Everything You Need to Know About the Upcoming Flu Season
To me, flu season is a lot like Christmas; there’s a defined time period when we expect it to occur, yet it seems to appear earlier and earlier......(read more)
Regeneron Pharmaceuticals Inc (REGN): Should You Follow in Sanofi SA (ADR) (SNY)’s Footsteps and Invest in This Booming Biotech?
More than anything, biotech companies need investors who are true believers in their products. In a sector more governed by future prospects than past......(read more)
SPDR S&P Homebuilders (ETF) (XHB), Abercrombie & Fitch Co. (ANF), Novartis AG (ADR) (NVS): Shorts Are Piling Into These Stocks. Should You Be Worried?
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long......(read more)
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive......(read more)
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Time to Bet on This Biotech Spinoff?
There hasn’t been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before......(read more)
Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does This Orphan Leukemia Treatment Have Blockbuster Potential?
When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen. However, more speculative......(read more)
Novartis AG (ADR) (NVS), Medtronic, Inc. (MDT): Will Smart Pills Revolutionize Health Care?
The ongoing convergence of the tech and health care industries has yielded some remarkable advances in telehealth, electronic health records, or EHRs,......(read more)
Hospira, Inc. (HSP), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK): Will This Biotech Approval Start a $100 Billion Trend?
Hospira, Inc. (NYSE:HSP) announced that the European Commission has approved its biosimilar version of Remicade from Johnson & Johnson (NYSE:JNJ......(read more)
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Will a Band-Aid Be Enough for Johnson & Johnson (JNJ)’s Latest Recall?
Check that bottle of Motrin Infants formula before you give it to a baby. Johnson & Johnson (NYSE:JNJ) recently announced a recall of around 200,000......(read more)
GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Theravance Inc (THRX) Gets Big Win for New COPD Drug
Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S. Food and Drug......(read more)
Johnson & Johnson (JNJ), Novartis AG (ADR) (NVS): The Cooper Companies, Inc. (COO) Leveraging Share Gains for Eye-Opening Growth
The Cooper Companies, Inc. (NYSE:COO), or more formally “The Cooper Companies” is a sort of odd duck in the med-tech world. It’s fairly......(read more)
Incyte Corporation (INCY), Pfizer Inc. (PFE): This Biotech Has So Many Reasons to Be Liked
Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only......(read more)
Johnson & Johnson (JNJ), Forest Laboratories, Inc. (FRX), Pfizer Inc. (PFE): Pharmas Spending the Most to Catch Your Doctor’s Eye
The way to your wallet just might be through your doctor’s eyes. Pharmaceutical firms spend a lot of money to influence physicians to prescribe......(read more)
